52 results
6-K
EX-99.1
PRFX
PainReform Ltd
26 Jun 24
PainReform Completes Enrollment in the Second Part
4:15pm
study, is designed to evaluate the efficacy and safety of PRF-110 in patients undergoing bunionectomy, a common outpatient surgical procedure … the total consumption of rescue analgesics and the overall safety and tolerability of PRF-110.
About PainReform
PainReform is a clinical-stage specialty
6-K
EX-99.2
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
is conducted;
length of time required to enroll eligible patients;
potential additional safety monitoring or other studies requested by regulatory … agencies; and
efficacy and safety profile of the drug candidate.
In addition, the probability of success for any of our current or future drug
6-K
EX-99.3
PRFX
PainReform Ltd
15 May 24
Condensed Financial Statements
4:15pm
serious adverse events, highlighting PRF-110’s favorable safety profile to date. Building on the success of the first part of our Phase 3 clinical trial
6-K
EX-99.1
PRFX
PainReform Ltd
9 Apr 24
Current report (foreign)
9:07am
on extended drug release technology, we believe PRF-110 is poised to set a new standard in topical pain management that prioritizes patient safety and efficacy
6-K
EX-99.1
PRFX
PainReform Ltd
2 Apr 24
PainReform Reaches 50% Enrollment in the Second Part of its Phase 3 Clinical
8:35am
, to date there have been no reported serious adverse events, underscoring PRF-110’s potential safety gathered until today. We're on track to wrap up
6-K
EX-99.1
hsb41z9sr4in4frwh
1 Mar 24
PainReform Provides Year-End Business Update
8:09am
6-K
EX-99.2
lxko w29yn
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.1
pupfk
11 Sep 23
Trial completion and results expected in mid-2024
8:41am
6-K
EX-99.2
o0j2p7m yic50qtd2
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.3
x52d2q00cvkdny
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.1
jih frasa
19 Jul 23
Current report (foreign)
9:08am
424B5
jzn f26pgdfu
18 Jul 23
Prospectus supplement for primary offering
11:59am
424B5
1635rba gfxpd9dskrvf
14 Jul 23
Prospectus supplement for primary offering
12:26pm
6-K
EX-99.1
wk3of3
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
EX-99.1
84u80kfu9 5ouhkc
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
EX-99.3
chy81nhoo6 w4dym
15 May 23
Condensed Financial Statements
4:51pm
6-K
EX-99.2
gqiexuqxw6t4410somh
15 May 23
Condensed Financial Statements
4:51pm
6-K
gd15llb6m1upkr3gxc9
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am
6-K
EX-99.1
o5sdc6kp6p qe
1 May 23
PainReform Announces Positive Safety Data in First Part of Phase 3 Clinical Trial of PRF-110 in Patients Undergoing Bunionectomy Surgery
8:41am